Preoperative patients' health decrease moderately, while hospital costs increase for hip and knee replacement due to the first COVID-19 lockdown in Germany.


Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 10 11 2021
accepted: 23 01 2022
pubmed: 26 2 2022
medline: 14 9 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

The purpose of this study was a comparison between osteoarthritis patients with primary hip and knee replacements before, during and after the first COVID-19 lockdown in Germany. Patients' preoperative health status is assumed to decrease, owing to delayed surgeries. Costs for patients with osteoarthritis were assumed to increase, for example, due to higher prices for protective equipment. Hence, a comparison of patients treated before, during and after the first lockdown is conducted. In total, 852 patients with primary hip or knee replacement were included from one hospital in Germany. Preoperative health status was measured with the WOMAC Score and the EQ-5D-5L. Hospital unit costs were calculated using a standardised cost calculation. Kruskal-Wallis tests and Chi-squared tests were applied for the statistical analyses. The mean of the preoperative WOMAC Score was slightly higher (p < 0.01) for patients before the first lockdown, compared with patients afterwards. Means of the EQ-5D-5L were not significantly different regarding the lockdown status (NS). Length of stay was significantly reduced by approximately 1 day (p < 0.001). Total inpatient hospital unit costs per patient and per day were significantly higher for patients during and after the first lockdown (p < 0.001). Preoperative health, measured with the WOMAC Score, worsened slightly for patients after the first lockdown compared with patients undergoing surgery before COVID-19. Preoperative health, measured using the EQ-5D-5L, was unaffected. Inpatient hospital unit costs increased significantly with the COVID-19 pandemic. Retrospective cohort study, III.

Identifiants

pubmed: 35211774
doi: 10.1007/s00167-022-06904-9
pii: 10.1007/s00167-022-06904-9
pmc: PMC8868037
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3304-3310

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01GY1603A

Informations de copyright

© 2022. The Author(s) under exclusive licence to European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA).

Références

Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Knee Surg Sports Traumatol Arthrosc. 2020 Aug;28(8):2435-2443
pubmed: 32556438
Clin Orthop Relat Res. 2018 Oct;476(10):2005-2014
pubmed: 30179956
Knee Surg Sports Traumatol Arthrosc. 2021 Aug;29(8):2379-2385
pubmed: 33710414
J Am Acad Orthop Surg. 2010 Feb;18(2):72-82
pubmed: 20118324
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
J Bone Joint Surg Am. 2020 Mar 4;102(5):404-409
pubmed: 31714468
BMC Musculoskelet Disord. 2019 May 17;20(1):227
pubmed: 31101033
Am J Infect Control. 2020 Aug;48(8):915-917
pubmed: 32464298
Value Health. 2017 Sep;20(8):1150-1156
pubmed: 28964448
Health Econ Rev. 2012 Aug 30;2(1):15
pubmed: 22935314
J Bone Joint Surg Am. 2018 Feb 21;100(4):326-333
pubmed: 29462036
Health Qual Life Outcomes. 2019 Dec 9;17(1):180
pubmed: 31815627
Health Econ. 2008 Jan;17(1 Suppl):S9-20
pubmed: 18186038
Acta Biomed. 2020 Nov 10;91(4):e2020150
pubmed: 33525204
Knee Surg Sports Traumatol Arthrosc. 2020 Sep;28(9):2730-2746
pubmed: 32844246
Bone Joint J. 2019 Aug;101-B(8):941-950
pubmed: 31362549
Int Orthop. 2015 Jul;39(7):1307-14
pubmed: 25711395
Orthopade. 2020 Jun;49(6):494-501
pubmed: 32436038
Health Qual Life Outcomes. 2014 Aug 07;12:108
pubmed: 25273621
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716

Auteurs

Caroline Schatz (C)

LMU Munich School of Management, Institute of Health Economics and Health Care Management, Ludwig-Maximilians-Universität München, Munich, Germany. schatz@bwl.lmu.de.
Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, Munich, Germany. schatz@bwl.lmu.de.

Reiner Leidl (R)

LMU Munich School of Management, Institute of Health Economics and Health Care Management, Ludwig-Maximilians-Universität München, Munich, Germany.
Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, Munich, Germany.

Werner Plötz (W)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.
Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.

Katharina Bredow (K)

Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, Munich, Germany.

Peter Buschner (P)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH